Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
115,426,245
-
Share change
-
-4,062,287
-
Total reported value
-
$429,384,343
-
Put/Call ratio
-
0%
-
Price per share
-
$3.72
-
Number of holders
-
143
-
Value change
-
-$13,663,123
-
Number of buys
-
62
-
Number of sells
-
67
Institutional Holders of PDL BIOPHARMA INC COM - COM (Y104L) as of Q1 2019
As of 31 Mar 2019,
PDL BIOPHARMA INC COM - COM (Y104L) was held by
143 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
115,426,245 shares.
The largest 10 holders included
BlackRock Inc., DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, Connor, Clark & Lunn Investment Management Ltd., NORTHERN TRUST CORP, BRANDES INVESTMENT PARTNERS, LP, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, and ROYAL BANK OF CANADA.
This page lists
143
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.